Company intelligence / Profile preview

VetMotl

Gaithersburg, Maryland, United Statesvetmotl.com ↗

Ownership: Private
Development stage: Commercial

Overview

VetMotl’s microfluidic sperm separation devices are commercially available and have demonstrated increased efficiencies in blast development and viable implantable embryos for equine and bovine ART procedures. The devices are also effective with other animal species. They offer improved sample quality compared to traditional methods and have been used successfully in numerous veterinary settings.

Therapeutic areas: EndocrinologyWomen's Health
Modalities: Device (Sperm separation device)
Industry: Veterinary

Partnerships

Texas Equine Veterinary Association (event sponsor/partner)

Beyond the preview

Go deeper on VetMotl.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VetMotl.

Explore the full profile